{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:48:35Z","timestamp":1776084515184,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012551","name":"Applied Basic Research Program of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["ZYN2022057"],"award-info":[{"award-number":["ZYN2022057"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2020YFC2005500"],"award-info":[{"award-number":["2020YFC2005500"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018927","name":"Southwest Minzu University","doi-asserted-by":"publisher","award":["RQD2022033"],"award-info":[{"award-number":["RQD2022033"]}],"id":[{"id":"10.13039\/501100018927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2019YFS0514"],"award-info":[{"award-number":["2019YFS0514"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YJ0128"],"award-info":[{"award-number":["2021YJ0128"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.actbio.2022.06.033","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T22:24:08Z","timestamp":1656541448000},"page":"321-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Polysialylated nanoinducer for precisely enhancing apoptosis and anti-tumor immune response in B-cell lymphoma"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-1389","authenticated-orcid":false,"given":"Qixiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongsheng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.actbio.2022.06.033_bib0001","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv. Ther."},{"issue":"5","key":"10.1016\/j.actbio.2022.06.033_bib0002","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdy092","article-title":"Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma","volume":"29","author":"Makita","year":"2018","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.actbio.2022.06.033_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17474086.2020.1796623","article-title":"Chemotherapy combinations for B-cell lymphoma and chemo-free approach in elderly patients: an update on best practice","volume":"13","author":"Santambrogio","year":"2020","journal-title":"Expert. Rev. Hematol."},{"issue":"5","key":"10.1016\/j.actbio.2022.06.033_bib0004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/1061186X.2013.878942","article-title":"Targeted liposomal drug delivery systems for the treatment of B cell malignancies","volume":"22","author":"Mittal","year":"2014","journal-title":"J. Drug Target"},{"key":"10.1016\/j.actbio.2022.06.033_bib0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2147\/DDDT.S152420","article-title":"Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system","volume":"12","author":"Qiu","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.actbio.2022.06.033_bib0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.actbio.2022.06.033_bib0007","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.trecan.2017.04.006","article-title":"Novel insights into membrane targeting of B cell lymphoma","volume":"3","author":"de Winde","year":"2017","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.actbio.2022.06.033_bib0008","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40259-013-0016-7","article-title":"Targeting CD22 in B-cell malignancies: current status and clinical outlook","volume":"27","author":"Sullivan-Chang","year":"2013","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.actbio.2022.06.033_bib0009","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4009","article-title":"Maturing antibody-drug conjugate pipeline hits 30","volume":"12","author":"Mullard","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.actbio.2022.06.033_bib0011","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-18-3784","article-title":"Modulation of target antigen density improves CAR T-cell functionality and persistence","volume":"25","author":"Ramakrishna","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.actbio.2022.06.033_bib0012","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.actbio.2022.06.033_bib0013","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1084\/jem.20011783","article-title":"The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound","volume":"195","author":"Kelm","year":"2002","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.actbio.2022.06.033_bib0014","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1002\/anie.202005934","article-title":"Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy","volume":"60","author":"Hong","year":"2021","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.actbio.2022.06.033_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2021.108376","article-title":"The polyfunctional polysialic acid: a structural view","volume":"507","author":"Mindler","year":"2021","journal-title":"Carbohydr. Res."},{"issue":"1-2","key":"10.1016\/j.actbio.2022.06.033_bib0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2005.06.007","article-title":"Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids","volume":"300","author":"Gregoriadis","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"13-14","key":"10.1016\/j.actbio.2022.06.033_bib0017","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/PL00000676","article-title":"Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics","volume":"57","author":"Gregoriadis","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0167-4838(95)00227-8","article-title":"Synthesis, characterization and properties of sialylated catalase","volume":"1293","author":"Fernandes","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"1-2","key":"10.1016\/j.actbio.2022.06.033_bib0019","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(01)00603-2","article-title":"The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics","volume":"217","author":"Fernandes","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2022.06.033_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105241","article-title":"Development of a nattokinase-polysialic acid complex for advanced tumor treatment","volume":"145","author":"Kou","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0304-4165(03)00116-8","article-title":"Polysialylated insulin: synthesis, characterization and biological activity in vivo","volume":"1622","author":"Jain","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.actbio.2022.06.033_bib0022","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s10529-010-0382-x","article-title":"Improvement of the CuZn-superoxide dismutase enzyme activity and stability as a therapeutic agent by modification with polysialic acids","volume":"32","author":"Wu","year":"2010","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0023","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/hae.13878","article-title":"SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): first-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A","volume":"26","author":"Tiede","year":"2020","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.actbio.2022.06.033_bib0024","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4155\/tde.13.153","article-title":"Polysialic acid: overcoming the hurdles of drug delivery","volume":"5","author":"Bader","year":"2014","journal-title":"Ther. Deliv."},{"issue":"1-2","key":"10.1016\/j.actbio.2022.06.033_bib0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijpharm.2016.10.051","article-title":"Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation","volume":"515","author":"Zhang","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.actbio.2022.06.033_bib0026","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"issue":"11","key":"10.1016\/j.actbio.2022.06.033_bib0027","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0028","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1038\/s41467-020-17772-7","article-title":"A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis","volume":"11","author":"Barth","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.actbio.2022.06.033_bib0029","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1002\/anie.202013987","article-title":"An ER-targeting iridium(III) complex that induces immunogenic cell death in non-small-cell lung cancer","volume":"60","author":"Wang","year":"2021","journal-title":"Angew. Chem. Int. Ed Engl."},{"issue":"10","key":"10.1016\/j.actbio.2022.06.033_bib0030","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1158\/1078-0432.CCR-09-3199","article-title":"Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model","volume":"16","author":"Tuscano","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.actbio.2022.06.033_bib0031","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpba.2009.09.027","article-title":"HPLC analysis of mitoxantrone in mouse plasma and tissues: application in a pharmacokinetic study","volume":"51","author":"An","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.actbio.2022.06.033_bib0032","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential - what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control Release"},{"issue":"9","key":"10.1016\/j.actbio.2022.06.033_bib0033","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1389200219666171207120643","article-title":"Long circulating polymeric nanoparticles for gene\/drug delivery","volume":"19","author":"Hu","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.actbio.2022.06.033_bib0034","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3389\/fimmu.2018.02235","article-title":"CD22: a regulator of innate and adaptive B cell responses and autoimmunity","volume":"9","author":"Clark","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2022.06.033_bib0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.actbio.2022.06.033_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch: immunogenic cell death induction by anticancer chemotherapeutics","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"issue":"29","key":"10.1016\/j.actbio.2022.06.033_bib0037","doi-asserted-by":"crossref","first-page":"44879","DOI":"10.18632\/oncotarget.9821","article-title":"Mitochondrial dysfunction and oxidative stress in aging and cancer","volume":"7","author":"Kudryavtseva","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.actbio.2022.06.033_bib0039","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front. Cell Neurosci."},{"issue":"12","key":"10.1016\/j.actbio.2022.06.033_bib0040","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"10.1016\/j.actbio.2022.06.033_bib0041","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1007\/s00253-018-9336-3","article-title":"Bioproduction, purification, and application of polysialic acid","volume":"102","author":"Wu","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"34","key":"10.1016\/j.actbio.2022.06.033_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102188","article-title":"Plasmon-driven catalytic chemotherapy augments cancer immunotherapy through induction of immunogenic cell death and blockage of IDO pathway","volume":"33","author":"Ding","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2022.06.033_bib0043","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.actbio.2022.06.033_bib0044","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","article-title":"In vivo CD4(+) T cell differentiation and function: revisiting the Th1\/Th2 paradigm","volume":"38","author":"Ruterbusch","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actbio.2022.06.033_bib0045","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic cells and CD8 T Cell Immunity in Tumor Microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2022.06.033_bib0046","first-page":"237","article-title":"Self-assembling, self-adjuvanting and fully synthetic peptide nanovaccine for cancer immunotherapy","volume":"2","author":"Song","year":"2021","journal-title":"Smart Mater. Med."},{"issue":"599","key":"10.1016\/j.actbio.2022.06.033_bib0047","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba9772","article-title":"Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models","volume":"13","author":"Lin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2022.06.033_bib0048","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2020.06.015","article-title":"Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal\/immunotherapy","volume":"326","author":"Zhang","year":"2020","journal-title":"J. Control Release"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122003725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122003725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:52:36Z","timestamp":1761673956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122003725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":48,"alternative-id":["S1742706122003725"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.06.033","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polysialylated nanoinducer for precisely enhancing apoptosis and anti-tumor immune response in B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}